# Development of a Raft-Forming System Using Plantago major Mucilage as a Natural Polymer for Sustained Gastric Release of Artemisia annua L. Phenolic Extract

**Authors:** Leila Ziaeifar, Maryam Salami, Gholamreza Askari, Zahra Emam-Djomeh, Raimar Loebenberg, Michael J. Serpe, Neal M. Davies

PMC · DOI: 10.3390/pharmaceutics18020225 · 2026-02-10

## TL;DR

This paper explores using a natural plant-based polymer to create a stomach-friendly gel that slowly releases a plant extract over time.

## Contribution

The study introduces Plantago major mucilage as a natural alternative to synthetic polymers for raft formation in drug delivery systems.

## Key findings

- Rafts made with 0.5% PMM showed better stability and improved properties compared to Carbomer-based rafts.
- The PMM raft system effectively prolonged the release of phenolic extracts from Artemisia annua L., with less than 30% released after 6 hours.

## Abstract

Background/Objectives: Alginate-based rafts are typically used for antacids and provide a floating, gastric-retaining gel in the stomach that acts as a barrier to the entrance of stomach acid into the esophagus. Various technologies have been developed to enhance the sustained release of drugs and bioactive components and overcome challenges associated with gastric retention. Modern methods, such as the alginate raft, not only function as an antacid in gastroesophageal reflux disease but also can serve as a delivery system that extends the drug release time in gastric medium. This study assessed the effects of biocompatible natural polymers, such as Plantago major mucilage (PMM), on raft formation instead of synthetic polymers, such as Carbomer. Methods: PMM was substituted in the raft formulation at concentrations of 0.5% and 1%. The formed rafts were analyzed for their physicochemical, mechanical, and structural properties. To evaluate the sustained release potential of the optimized raft formulation, the aqueous extract of Artemisia annua L. was incorporated into coconut protein nanoparticles and loaded into the optimized raft at three different concentrations of 1%, 2%, and 3%. Results: The rafts formulated with PMM 0.5% revealed excellent stability of the suspension, as well as improved physicochemical properties of the developed rafts compared to the raft that included Carbomer. The results illustrated that the inclusion of PMM in the raft system enhances antacid capacity, swelling percentage, resilience time, strength, and a stiffer gel with a higher G′. Conclusions: The optimized PMM raft was able to prolong the in vitro release of phenolic extracts and reach the cumulative release of less than 30% after 6 h.

## Linked entities

- **Diseases:** gastroesophageal reflux disease (MONDO:0007186)
- **Species:** Plantago major (taxon 29818)

## Full-text entities

- **Diseases:** indigestion (MESH:D004415), cardiac diseases (MESH:D006331), heartburn (MESH:D006356), mucosal damage (MESH:D052016), kidney disorders (MESH:D007674), Inflammatory disorders of the stomach (MESH:D013272), ulcer (MESH:D014456), peptic ulcer disease (MESH:D010437), bronchitis (MESH:D001991), PMM (MESH:D004830), dysphagia (MESH:D003680), iron deficiency anemia (MESH:D018798), pneumonia (MESH:D011014), chest pain (MESH:D002637), obesity (MESH:D009765), bleeding (MESH:D006470), gastric cancer (MESH:D013274), abdominal pain (MESH:D015746), diabetic (MESH:D003920), hypomagnesemia (OMIM:613882), infection with Helicobacter pylori (MESH:D016481), inflammation (MESH:D007249), neurodegeneration (MESH:D019636), injury to (MESH:D014947), gastric ulcer (MESH:D013276), GERD (MESH:D005764)
- **Chemicals:** calcium (MESH:D002118), alginic acid (MESH:D000077322), beta-glucans (MESH:D047071), flavonoids (MESH:D005419), chlorogenic acid (MESH:D002726), glucose (MESH:D005947), CPNP (MESH:C072937), hydrogen (MESH:D006859), alcohol (MESH:D000438), caffeic acid (MESH:C040048), tryptophan (MESH:D014364), gellan gum (MESH:C048288), sodium carbonate (MESH:C005686), arabinose (MESH:D001089), xylose (MESH:D014994), vitamin B12 (MESH:D014805), AAP10 (MESH:C090806), CO2 (MESH:D002245), Polyphenol (MESH:D059808), carbohydrate (MESH:D002241), phenylalanine (MESH:D010649), phenols (MESH:D010636), galacturonic acid (MESH:C007819), Amino acids (MESH:D000596), coconut oil (MESH:D000074263), rhamnose (MESH:D012210), glucuronic acid (MESH:D020723), curcumin (MESH:D003474), CPC (-), NaHCO3 (MESH:D017693), galactose (MESH:D005690), NaOH (MESH:D012972), xanthan gum (MESH:C002563), Gaviscon (MESH:C007829), ethanol (MESH:D000431), HCl (MESH:D006851), xyloglucans (MESH:C029353), KBr (MESH:C039004), F4 (MESH:C006011), catechins (MESH:D002392), ferulic acid (MESH:C004999), sodium azide (MESH:D019810), water (MESH:D014867), phenol (MESH:D019800), tyrosine (MESH:D014443), polymer (MESH:D011108), Konjac glucomannan (MESH:C022901), metronidazole (MESH:D008795), Hydroxypropyl methyl cellulose (MESH:D065347), Carbopol 934 (MESH:C453622), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), Carbomer (MESH:C479038), pectin (MESH:D010368), polysaccharide (MESH:D011134), gallic acid (MESH:D005707), aromatic amino acids (MESH:D024322), Alginates (MESH:D000464), chitosan (MESH:D048271), COO (MESH:C041069), acrylic acid (MESH:C036658)
- **Species:** Homo sapiens (human, species) [taxon 9606], Phaeophyceae (brown algae, class) [taxon 2870], Helicobacter pylori (species) [taxon 210], Plantago major (cart-track plant, species) [taxon 29818], Hyphomicrobium sp. PMC (species) [taxon 161967], Artemisia annua (sweet Annie, species) [taxon 35608], Philodinidae sp. MM (species) [taxon 1659253]
- **Mutations:** K100M

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943903/full.md

---
Source: https://tomesphere.com/paper/PMC12943903